REPORT HIGHLIGHT
Contraceptive Drugs Market size was valued at USD 17,501.01 Million in 2022, expanding at a CAGR of 7.67% from 2023 to 2030.
Contraceptives, a category of pharmaceuticals, serve as tools to regulate and manage the reproductive process, thereby offering individuals and couples the means to prevent unintended pregnancies. These contraceptives are available in various forms, including oral tablets, injectables, patches, and intrauterine devices (IUDs), each employing distinct mechanisms of action. They might function by suppressing ovulation, altering cervical mucus consistency to impede sperm mobility, or modifying the uterine lining to deter embryo implantation. The use of contraceptive pharmaceuticals provides people with the capacity to make informed decisions about family planning and reproductive well-being, affording them a reliable and reversible approach to regulate their fertility.
Contraceptive Drugs Market- Market Dynamics
Increasing Prevalence of sexually transmitted illnesses to propel market demand
In response to ongoing population growth and the rising incidence of STDs, governmental bodies have been compelled to enforce stringent birth control measures. Numerous governmental and non-governmental organizations have introduced an array of family planning and pregnancy prevention campaigns. Initiatives from entities like gynecological divisions, family planning associations, women's health management groups, and contraception advocates have made significant strides in ensuring the accessibility and adequacy of contraceptives. When compared to traditional therapies and drugs, modern contraceptive methods offer higher efficacy and provide more comprehensive protection against STDs. Consequently, the general population is increasingly embracing and adopting contemporary solutions such as oral contraceptives, sterilization, and other innovative products.
Contraceptive Drugs Market- Key Insights
According to insights from our research analyst, the global Contraceptive Drugs market is poised to experience steady annual growth, with an estimated CAGR of approximately 7.67% throughout the forecast period from 2023 to 2030.
The Contraceptive Drugs industry is expected to demonstrate significant expansion, primarily attributed to the rising incidence of sexually transmitted diseases, emphasizing the importance of effective contraceptive measures.
In terms of Product segmentation, the market landscape in 2022 witnessed oral contraceptive pills as the dominant segment, contributing substantially to the market's share.
Furthermore, the Distribution Channel segmentation highlighted retail pharmacies as the leading type in 2022, underscoring the accessibility of these products to consumers.
Among the end-user segments, homecare emerged as the dominant category in 2022, reflecting the growing trend of self-administered contraceptive options.
Contraceptive Drugs Market- Segmentation Analysis:
The Global Contraceptive Drugs Market exhibits a segmentation based on Product, Distribution Channel, and Region.
Within this market, Product segmentation offers three distinctive categories: Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. Notably, the Oral Contraceptive Pills category dominates the landscape, capturing the largest market share. This can be attributed to the widespread adoption of oral contraceptives in both developed and emerging economies across the globe. The significant demand surge for oral contraceptives can be attributed to their numerous clinical advantages over alternative contraceptive forms like injectables and patches.
Contraceptive Drugs Market- Geographical Insights
The global Contraceptive Drugs Market extends its reach across several regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions, in turn, encompass individual nations that actively contribute to the market's growth. North America, with the United States as a significant player, is poised to take the lead. This is primarily due to the dominant market position of the United States and the region's extensive awareness and understanding of contraceptive pills.
Contraceptive Drugs Market- Competitive Landscape:
Enterprises utilize a wide array of channels to distribute their products, including their corporate websites, e-commerce platforms, partnerships with retailers, extensive distributor networks, and direct-to-consumer sales. These companies engage in robust competition on several fronts, encompassing price competitiveness, product performance, manufacturing excellence, an efficient distribution network, brand reputation, and product availability. To reinforce their market presence and augment their market share, businesses often employ diverse strategies, such as launching new products, expanding their distribution networks, increasing investments in research and development, and pursuing mergers and acquisitions. Notably, Lupin secured provisional approval from the U.S. Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), allowing the company to market a generic version of Slynd Tablets, a product by Exeltis USA Inc., further reinforcing the competitive landscape.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CONTRACEPTIVE DRUGS MARKET KEY PLAYERS
- Teva Pharmaceuticals
- Pfizer Inc.
- Novartis Pharmaceuticals
- Mylan N.V. (now part of Viatris Inc.)
- Merck & Co., Inc.
- Lupin Limited
- Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)
- Glenmark Pharmaceuticals
- Ferring Pharmaceuticals
- Evofem Biosciences
- CooperSurgical, Inc. (acquired by The Cooper Companies)
- Church & Dwight Co., Inc. (maker of Trojan condoms)
- Bayer AG
- Allergan (now part of AbbVie)
- Agile Therapeutics
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY PRODUCT
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Hospitals
- Clinics
- Retail Pharmacy
- Online Channel
- Public Channel & NGOs
- Others
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY END-USER
- Homecare
- Hospitals
- Clinics
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Contraceptive Drugs Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Contraceptive Drugs Market Snippet by Product
- 2.1.2. Contraceptive Drugs Market Snippet by Distribution Channel
- 2.1.3. Contraceptive Drugs Market Snippet by End-user
- 2.1.4. Contraceptive Drugs Market Snippet by Country
- 2.1.5. Contraceptive Drugs Market Snippet by Region
- 2.2. Competitive Insights
3. Contraceptive Drugs Key Market Trends
- 3.1. Contraceptive Drugs Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Contraceptive Drugs Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Contraceptive Drugs Market Opportunities
- 3.4. Contraceptive Drugs Market Future Trends
4. Contraceptive Drugs Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Contraceptive Drugs Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Contraceptive Drugs Market Landscape
- 6.1. Contraceptive Drugs Market Share Analysis, 2022
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Contraceptive Drugs Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
- 7.1.2. Oral Contraceptive Pills
- 7.1.3. Injectable Contraceptives
- 7.1.4. Topical Contraceptives
8. Contraceptive Drugs Market - By Distribution Channel
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
- 8.1.2. Hospitals
- 8.1.3. Clinics
- 8.1.4. Retail Pharmacy
- 8.1.5. Online Channel
- 8.1.6. Public Channel & NGOs
- 8.1.7. Others
9. Contraceptive Drugs Market - By End-user
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End-user, 2022 & 2030 (%)
- 9.1.2. Homecare
- 9.1.3. Hospitals
- 9.1.4. Clinics
10. Contraceptive Drugs Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Contraceptive Drugs Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Contraceptive Drugs Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Contraceptive Drugs Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Contraceptive Drugs Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Contraceptive Drugs Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Contraceptive Drugs Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Teva Pharmaceuticals
- 11.2.2. Pfizer Inc.
- 11.2.3. Novartis Pharmaceuticals
- 11.2.4. Mylan N.V. (now part of Viatris Inc.)
- 11.2.5. Merck & Co., Inc.
- 11.2.6. Lupin Limited
- 11.2.7. Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)
- 11.2.8. Glenmark Pharmaceuticals
- 11.2.9. Ferring Pharmaceuticals
- 11.2.10. Evofem Biosciences
- 11.2.11. CooperSurgical, Inc. (acquired by The Cooper Companies)
- 11.2.12. Church & Dwight Co., Inc. (maker of Trojan condoms)
- 11.2.13. Bayer AG
- 11.2.14. Allergan (now part of AbbVie)
- 11.2.15. Agile Therapeutics
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us